Goldman Sachs
PRVA icon

Goldman Sachs’s Privia Health PRVA Stock Holding History

Goldman Sachs’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.5M Sell
1,302,019
-37,931
-3% -$879K ﹤0.01% 2156
2026
Q1 		$27.6M Buy
1,339,950
+445,248
+50% +$10M ﹤0.01% 2134
2025
Q4 		$21.2M Buy
894,702
+258,430
+41% +$6.29M ﹤0.01% 2319
2025
Q3 		$15.8M Buy
636,272
+96,023
+18% +$2.07M ﹤0.01% 2492
2025
Q2 		$12.4M Sell
540,249
-144,224
-21% -$3.34M ﹤0.01% 2565
2025
Q1 		$15.4M Sell
684,473
-240,884
-26% -$5.6M ﹤0.01% 2282
2024
Q4 		$18.1M Buy
925,357
+325,832
+54% +$6.46M ﹤0.01% 2219
2024
Q3 		$10.9M Buy
599,525
+355,120
+145% +$6.78M ﹤0.01% 2618
2024
Q2 		$4.25M Buy
244,405
+82,901
+51% +$1.47M ﹤0.01% 3315
2024
Q1 		$3.16M Buy
161,504
+32,452
+25% +$685K ﹤0.01% 3503
2023
Q4 		$2.97M Buy
129,052
+119,407
+1,238% +$2.67M ﹤0.01% 3606
2023
Q3 		$222K Sell
9,645
-257
-3% -$6.54K ﹤0.01% 5006
2023
Q2 		$259K Sell
9,902
-24,817,619
-100% -$655M ﹤0.01% 5084
2023
Q1 		$685M Buy
24,827,521
+2,930
+0% +$77.3K 0.16% 111
2022
Q4 		$564M Sell
24,824,591
-3,187,612
-11% -$88.7M 0.14% 132
2022
Q3 		$954M Buy
28,012,203
+98,834
+0.4% +$3.65M 0.24% 65
2022
Q2 		$813M Sell
27,913,369
-97,088
-0.3% -$2.47M 0.2% 83
2022
Q1 		$749M Buy
28,010,457
+3,010
+0% +$71.1K 0.16% 104
2021
Q4 		$725M Sell
28,007,447
-2,507,042
-8% -$62.5M 0.14% 118
2021
Q3 		$719M Buy
30,514,489
+860
+0% +$30K 0.15% 115
2021
Q2 		$1.35B Buy
+30,513,629
New +$1.13B 0.3% 46

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Goldman Sachs's PRVA Position: Q2 2026 in Review

Goldman Sachs reduced its Privia Health (PRVA) stake by 2.8% in Q2 2026, selling an estimated $879K and leaving 1,302,019 shares worth $33.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Goldman Sachs first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.35B in Q2 2021. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Goldman Sachs held 1,302,019 shares of Privia Health worth $33.5M as of Q2 2026.
  • Goldman Sachs sold 37,931 Privia Health shares in Q2 2026, an estimated $879K.
  • Privia Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2156 holding.
  • Goldman Sachs first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Goldman Sachs's Privia Health position peaked at $1.35B in Q2 2021.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.